Cislini Jeff: insider trades.
Cislini Jeff reported 11 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($12.7M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 9
- Companies
- 1
- Name as filed
- Cislini Jeff
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Officer · SVP & General Counsel | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-25 | Revolution Medicines, Inc. | S | 765 | $207.32 | 51,776 | Form 4 |
| 2026-09-16 | Revolution Medicines, Inc. | S | 52 | $195.01 | 55,855 | Form 4 |
| 2026-09-16 | Revolution Medicines, Inc. | S | 3,314 | $199.3 | 52,541 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | M | 29,680 | $18.56 | 86,201 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 2,540 | $210.26 | 63,721 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 3,314 | $212.06 | 55,907 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 4,500 | $211.34 | 59,221 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 3,400 | $207.24 | 109,401 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 25,817 | $209.25 | 66,261 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 17,323 | $208.37 | 92,078 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | M | 26,600 | $21.61 | 112,801 | Form 4 |
Questions
What stock did Cislini Jeff buy or sell?
Cislini Jeff reported 11 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($12.7M), across 1 company.
Is Cislini Jeff the same person as other filers with this name?
This page covers SEC CIK 1969082 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/cislini-jeff-1969082.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.